This lawsuit could end the myth of ‘settled’ gender science

The Federal Trade Commission's lawsuit against the World Professional Association for Transgender Health is a significant move that challenges long-standing, yet controversial, guidelines in pediatric gender medicine. The complaint alleges that WPATH's recommendations have been based on flimsy evidence and disregard for basic biological principles, which has led to widespread mistrust in their practices. This legal action could fundamentally reshape the discourse around gender science, pushing for more rigorous and evidence-based approaches to medical care. The implications are vast, potentially affecting the treatment protocols and the perception of medical honesty in the transgender community.